RPS27L and neoplasm: Three other stage III patients, who suffered recurrence within one year after surgery and died after the first recurrence (survival <4 years), were also positive for p53 protein in their tumor cells, but the expression of RPS27L protein was weak at the corresponding positions (Figure 1B, patients 4–6).